Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country: Opportunities and Forecast (2016-2021)
• By Product Type- Vaccines, Therapeutics • By Therapeutics - Relenza (Zanamivir), Tamiflu (Oseltamivir Phosphate), Rapivab (Peramivir) • By Region-North America, Europe, APAC, ROW • By Country – US, Canada, UK, France, India, China • Policy & Regulations • Pipeline Analysis
1 May 2017
Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country (2016-2021) Scope of the Study
Global Coverage Regional Coverage Country Coverage
Global Coverage
Segment Coverage Drugs Type Vaccines Type
By Drugs - Zanamivir, Oseltamivir Phosphate, Peramivir By Vaccines – Trivalent, Quadrivalent
Regional Coverage
North America Europe Asia Pacific ROW
Influenza Market (2011-15) Influenza Market (2016-21) Breakdown-By Product Type
Country Coverage
U.S. Canada U.K. France India China
Therapeutics (2011-2015) Therapeutics (2016-2021)
Company Coverage Teva Pharmaceutical Industries Ltd. Emergent Biosolutions Sanofi Pasteur, Inc. GlaxoSmithKline Merck & Co., Inc. CSL Limited Astrazeneca Pfizer Serum Institute Of India Pvt. Ltd. Protein Sciences Corporation
Vaccines Market (2011-15) Vaccines Market (2016-21) Breakdown-By Therapeutics Type Relenza (zanamivir) Tamiflu (oseltamivir phosphate) Rapivab (peramivir) Breakdown – By Vaccine Type Trivalent Vaccine Quadrivalent Vaccine
Influenza Market(2011-15) Influenza Market (2016-21) Influenza Market : By Product Type (2011-15) Influenza Market : By Product Type (2016-21)
Anti-Infective Vaccines Market (2011-15) Anti-Infective Vaccines Market (2016-21)
Product Benchmarking Policy and Regulatory Landscape Financial Analysis Sales Business Strategy Market Entry Strategy
2
S.No 1.
2.
3.
Particulars
Page No.
Introduction
14
1.1.
Research Methodology
14
1.2.
Executive Summary
15
1.3.
Strategic Recommendation
16
1.3.
Product Overview
17
Global Influenza Market Overview
21
2.1.
Global Influenza Market Size, By Value, Historic, 2011-2015
22
2.2.
Global Influenza Market Size, By Value, Forecast, 2016-2021
23
Global Influenza Market, Product Analysis
24
3.1.
By Product-Actual(2015)
25
3.2.
By Product-Forecast(2021)
26
3.3.
Global Influenza Therapeutics Market , Historic, 2011-2015
27
3.4.
Global Influenza Therapeutics Market ,Forecast, 2016-2021
28
3.5.
Global Influenza Vaccines Market, Historic, 2011-2015
29
3.6.
Global Influenza Vaccines Market, Forecast, 2016-2021
30
3.7.
Global Influenza Therapeutics Market, By Drug Type
31
3.7.1.
Global Zanamivir Market , Historic, 2011-2015
32
3.7.2.
Global Zanamivir Market , Forecast, 2016-2021
33
3.7.3.
Global Oseltamivir Phosphate Market ,
Historic, 2011-2015
35
3.7.4.
Global Oseltamivir Phosphate Market , Forecast, 2016-2021
36
3.7.5.
Global Peramivir Market , Forecast, 2016-2021
38
3.8.
Global Influenza Vaccines Market, By Vaccine Type
39
3.8.1.
Global Trivalent Vaccines Market , Historic, 2011-2015
40
3.8.2.
Global Trivalent Vaccines Market , Forecast, 2016-2021
41
3.8.3.
Global Quadrivalent Vaccines Market ,
Historic, 2011-2015
43
3.8.4.
Global Quadrivalent Vaccines Market , Forecast, 2016-2021
44
(c) AZOTH Analytics
3
S.No
Particulars
Page No.
4.
Global Influenza Vaccines & Drugs - Pipeline Analysis
46
5.
Global Influenza Market, By Region
48
5.1.
By Region-Actual(2015)
49
5.2.
By Region-Actual(2021)
50
6.
7.
North America Influenza Market Overview
51
6.1.
North America Influenza Market Size, By Value, Historic, 2011-2015
52
6.2.
North America Influenza Market Size, By Value, Forecast, 2016-2021
53
6.3.
North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
55
6.4.
North America Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021
56
6.5.
North America Influenza Vaccines Market Size, By Value, Historic 2011-2015
58
6.6.
North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
59
6.7.
North America Influenza Therapeutics: Segment Analysis
60
6.8.
North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
61
6.9.
North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
62
6.10.
North America Influenza Vaccines: Segment Analysis
63
6.11.
North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
64
6.12.
North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
65
United States Influenza Market Overview
66
7.1.
United States Influenza Market Size, By Value, Historic, 2011-2015
67
7.2.
United States Influenza Market Size, By Value, Forecast, 2016-2021
67
7.3.
United States Influenza Therapeutics Market Size, By Value, Historic 2011-2015
69
7.4.
United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
69
7.5.
United States Influenza Vaccines Market Size, By Value, Historic 2011-2015
71
7.6
United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
71
7.7.
Canada Influenza Market Size, By Value, Historic, 2011-2015
73
7.8.
Canada Influenza Market Size, By Value, Forecast, 2016-2021
73
(c) AZOTH Analytics
4
S.No
8.
9.
Particulars
Page No.
7.9.
Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015
75
7.10.
Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
75
7.11.
Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015
77
7.12.
Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
77
7.13.
North America Other Influenza Market Size, By Value, Historic, 2011-2015
79
7.14.
North America Other Influenza Market Size, By Value, Forecast, 2016-2021
79
Europe Influenza Market Overview
80
8.1.
Europe Influenza Market Size, By Value, Historic, 2011-2015
81
8.2.
Europe Influenza Market Size, By Value, Forecast, 2016-2021
82
8.3.
Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
84
8.4.
Europe Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021
85
8.5.
Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015
87
8.6.
Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
88
8.7.
Europe Influenza Therapeutics: Segment Analysis
89
8.8.
Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
90
8.9.
Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
91
8.10.
Europe Influenza Vaccines: Segment Analysis
92
8.11.
Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
93
8.12.
Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
94
United Kingdom Influenza Market Overview
95
9.1.
United Kingdom Influenza Market Size, By Value, Historic, 2011-2015
96
9.2.
United Kingdom Influenza Market Size, By Value, Forecast, 2016-2021
96
9.3.
United Kingdom Influenza Therapeutics Market Size, By Value, Historic 2011-2015
98
9.4.
United Kingdom Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
98
9.5.
United Kingdom Influenza Vaccines Market Size, By Value, Historic 2011-2015
100
9.6
United Kingdom Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
100
(c) AZOTH Analytics
5
S.No 10.
11.
Particulars
Page No.
France Influenza Market Overview
101
10.1.
France Influenza Market Size, By Value, Historic, 2011-2015
102
10.2.
France Influenza Market Size, By Value, Forecast, 2016-2021
102
10.3.
France Influenza Therapeutics Market Size, By Value, Historic 2011-2015
104
10.4.
France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
104
10.5.
France
Influenza Vaccines Market Size, By Value, Historic 2011-2015
106
10.6.
France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
106
10.7.
Europe Other Influenza Market Size, By Value, Historic, 2011-2015
108
10.8.
Europe Other Influenza Market Size, By Value, Forecast, 2016-2021
108
APAC Influenza Market Overview
109
11.1.
APAC Influenza Market Size, By Value, Historic, 2011-2015
110
11.2.
APAC Influenza Market Size, By Value, Forecast, 2016-2021
111
11.3.
APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015
113
11.4.
APAC Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021
114
11.5.
APAC Influenza Vaccines Market Size, By Value, Historic 2011-2015
116
11.6.
APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
117
11.7.
APAC Influenza Therapeutics: Segment Analysis
118
11.8.
APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
119
11.9.
APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
120
11.10.
APAC Influenza Vaccines: Segment Analysis
121
11.11.
APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
122
11.12.
APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021
123
(c) AZOTH Analytics
6
S.No 12.
13.
Particulars India Influenza Market Overview
Page No. 124
12.1.
India Influenza Market Size, By Value, Historic, 2011-2015
125
12.2.
India Influenza Market Size, By Value, Forecast, 2016-2021
125
12.3.
India Influenza Therapeutics Market Size, By Value, Historic 2011-2015
127
12.4.
India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
127
12.5.
India Influenza Vaccines Market Size, By Value, Historic 2011-2015
128
12.6.
India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
128
China Influenza Market Overview
129
13.1.
China Influenza Market Size, By Value, Historic, 2011-2015
130
13.2.
China Influenza Market Size, By Value, Forecast, 2016-2021
130
13.3.
China Influenza Therapeutics Market Size, By Value, Historic 2011-2015
132
13.4.
China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
132
13.5.
China Influenza Vaccines Market Size, By Value, Historic 2011-2015
134
13.6.
China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
134
13.7.
APAC Other Influenza Market Size, By Value, Historic, 2011-2015
136
13.8.
APAC Other Influenza Market Size, By Value, Forecast, 2016-2021
136
(c) AZOTH Analytics
7
S.No 14.
15.
16.
Particulars ROW Influenza Market Overview
137
14.1.
ROW Influenza Market Size, By Value, Historic, 2011-2015
138
14.2.
ROW Influenza Market Size, By Value, Historic , 2016-2021
139
Market Dynamics
140
15.1.
Drivers
140
15.2.
Challenges
145
15.3.
Trends
148
Company Profiles
153
16.1.
GlaxoSmithKline
154
16.2.
Sanofi Pasteur, Inc.
155
16.3.
CSL Limited
156
16.4.
Astrazeneca
157
16.5.
Protein Sciences Corporation
158
16.6.
Serum Institute Of India Pvt. Ltd.
159
16.7.
Emergent Biosolutions
160
16.8.
Gilead Sciences
161
16.9. 16.10. 17.
Page No.
BioCryst Pharmaceuticals.Inc.
162
Alvogen
163
About Us
164
(c) AZOTH Analytics
8
List of Figures Figure No.
Figure Title
Page No.
Figure 1:
Global Influenza Market Size, By Value, 2011-2015 (USD Billion)
22
Figure 2:
Global Influenza Market Size, By Value, 2016E-2021F (USD Billion)
23
Figure 3:
Global Influenza Market Size and Share, By Product, 2015
25
Figure 4:
Key Drivers
25
Figure 5:
Global Influenza Market Size and Share, By Product, 2021F
26
Figure 6:
Key Drivers
26
Figure 7:
Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
27
Figure 8:
Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
28
Figure 9:
Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
29
Figure 10:
Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
30
Figure 11:
Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion)
32
Figure 12:
Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion)
33
Figure 13:
Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion)
35
Figure 14:
Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion)
36
Figure 15:
Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion)
38
Figure 16:
Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
40
Figure 17:
Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
41
Figure 18:
Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
43
Figure 19:
Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion
44
9
List of Figures Figure No.
Figure Title
Page No.
Figure 20:
Global Influenza Market Size and Share, By Region, 2015
49
Figure 21:
Key Drivers
49
Figure 22:
Global Influenza Market Size and Share, By Region, 2021F
50
Figure 23:
Key Drivers
50
Figure 24:
North America Influenza Market Size, By Value, 2011-2015 (USD Billion)
52
Figure 25:
North America Influenza Market Size, By Value, 2016E-2021F (USD Billion)
53
Figure 26:
North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
55
Figure 27:
North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
56
Figure 28:
North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
58
Figure 29:
North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
59
Figure 30:
North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
61
Figure 31:
North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
62
Figure 32:
North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
64
Figure 33:
North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
65
Figure 34:
US Influenza Market Size, By Value, 2011-2021(USD Billion)
67
Figure 35:
US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
69
Figure 36:
US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
71
10
List of Figures Figure No.
Figure Title
Page No.
Figure 37:
Canada Influenza Market Size, By Value, 2011-2021(USD Billion)
73
Figure 38:
Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
75
Figure 39:
Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
77
Figure 40:
North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
79
Figure 41:
Europe Influenza Market Size, By Value, 2011-2015 (USD Billion)
81
Figure 42:
Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion)
82
Figure 43:
Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
84
Figure 44:
Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
85
Figure 45:
Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
87
Figure 46:
Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
88
Figure 47:
Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
90
Figure 48:
Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
91
Figure 49:
Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
93
Figure 50:
Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
94
Figure 51:
UK Influenza Market Size, By Value, 2011-2021(USD Billion)
96
Figure 52 :
UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
98
Figure 53 :
UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
100
11
List of Figures Figure No.
Figure Title
Page No.
Figure 54:
France Influenza Market Size, By Value, 2011-2021(USD Billion)
102
Figure 55:
France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
104
Figure 56:
France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
106
Figure 57:
Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
108
Figure 58:
APAC Influenza Market Size, By Value, 2011-2015 (USD Billion)
110
Figure 59:
APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion)
111
Figure 60:
APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion
113
Figure 61:
APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
114
Figure 62:
APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
116
Figure 63:
APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
117
Figure 64:
APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
119
Figure 65:
APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
120
Figure 66:
APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
122
Figure 67:
APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
123
Figure 68:
India Influenza Market Size, By Value, 2011-2021(USD Billion)
125
Figure 69:
India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
127
Figure 70:
India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
128
12
List of Figures Figure No.
Figure Title
Page No.
Figure 71:
China Influenza Market Size, By Value, 2011-2021(USD Billion)
130
Figure 72:
China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
132
Figure 73:
China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
134
Figure 74:
APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
136
Figure 75:
ROW Influenza Market Size, By Value, 2011-2015 (USD Million)
138
Figure 76:
ROW Influenza Market Size, By Value, 2016E-2021F (USD Million)
139
Table A:
Influenza Pipe analysis
46
Table B:
Influenza Pipe analysis
47
13
Global Influenza Market- Product Analysis Rising number of cases around the globe along with rising awareness regarding the drug have been propelling the market for influenza vaccination.
Figure : Global Influenza Market Size and Share, By Product, 2015
Figure : Key Drivers
14.83% Vaccines
Therapeutics
85.17%
Source: Azoth Analytics
14
Global Influenza Vaccines Market Rising affordability of the population along with increasing awareness among them and development of a global vaccine is anticipated to drive the market in the forecast period.
Figure : Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) CAGR: xxx%
2016E
2017F
2018F
2019F
2020F
2021F
Source: Azoth Analytics Estimates xxxx xxxxx xxxxx Xxxx •
.
Xxxx xxxx
15
North America Influenza Therapeutics Market Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
2016E
2017F
2018F Zanamivir
2019F Oseltamivir phosphate
2020F
2021F
Peramivir
CAGR 2016E-2021F Zanamivir: x% , Oseltamivir Phosphate: x%, Peramivir: x% Source: Azoth Analytics Estimates
Xx Xx Xx Xx xx
16
France Influenza Market Overview France Influenza Market is witnessing growth due to high penetration of vaccines and drugs in this country as compared to other less developed countries.
Figure : France Influenza Market Size, By Value, 2011-2021(USD Billion) CAGR: xxx%
CAGR: xxx%
2011
2012
2013
2014
2015
2016E
2017F
2018F
2019F
2020F
2021F
Source: Azoth Analytics Estimates xxxx xxxxx xxxx xxxx •
.
xxxxx
17
APAC Others Influenza Market Overview The changed perception of the general population and continuous improvements in the formulations of the vaccines and drugs is leading to the growth of this market.
Figure : APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
CAGR:xxx%
0.130
0.144
0.159
2011
2012
2013
CAGR: xxx%
0.174
0.188
0.217
0.246
0.275
2014
2015
2016E
2017F
2018F
0.304
0.334
0.364
2019F
2020F
2021F
Source: Azoth Analytics Estimates xxxx xxxx xxxx xxxxx xxxxx •
.
xxxxx
18
Research Methodology For our study on Global Influenza Drugs and Vaccines Market , we have conducted comprehensive secondary research followed by an extensive primary research. In the process of secondary research, we have scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of the Influenza Drugs and Vaccines Market . Market size of the actual period (2011-2016) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies are scanned to further validate the market size and to estimate the size of various other end-user sectors. Market sizing and growth in the forecast period (2017-2022) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.
Report Focus: Global Influenza Drugs and Vaccines Market -By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), -By Vaccine (Trivalent, Quadrivalent) -By Region (North America, Europe, APAC, ROW), -By Country (U.S., Canada, U.K., Germany, France, China, India, Japan) -Company Analysis - Falvogen, Gilead Science and Bio Cryst
19
Report Ordering Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021)- - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)
Publish Date: May 2017 No. of Pages:164 Price: USD 2000 (Single User License) Price: USD 3000 (Multi- User License)
To View Sample Report or Purchase Report Click Here
Contact Us ASIA PACIFIC
EUROPE
Mail: info@azothanalytics.com Phone: +91 120 429 8235 NORTH AMERICA
Mail: shipra@azothanalytics.com Phone: +44 - 744 - 8107625 Call for Assistance
Mail: tanvi@azothanalytics.com Phone: +1 - 321 - 444 9707
Phone: +91 9873 4262 88 Sales Enquiry Phone: +91 120 429 8235
www.azothanalytics.com
20